Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol

B.A. Brand; J.N. de Boer; S.B.J.O. Ophuis; M.I.E. Slot; B. De Wilde; K.C.E.E.R. Catthoor; A.J. Goverde; P.R. Bakker; M.C. Marcelis; K.P. Grootens; J.J. Luykx; S.M. Heringa; C.S. Weickert; I.E.C. Sommer; T.W. Weickert

doi:10.1016/j.conctc.2020.100681

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol

B.A. Brand^*, J.N. de Boer, S.B.J.O. Ophuis, M.I.E. Slot, B. De Wilde, K.C.E.E.R. Catthoor, A.J. Goverde, P.R. Bakker, M.C. Marcelis, K.P. Grootens, J.J. Luykx, S.M. Heringa, C.S. Weickert, I.E.C. Sommer, T.W. Weickert

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Web of Science)

Original language	English
Article number	100681
Number of pages	8
Journal	Contemporary Clinical Trials Communications
Volume	20
DOIs	https://doi.org/10.1016/j.conctc.2020.100681
Publication status	Published - 1 Dec 2020

Keywords

antipsychotic medication
cognition
double-blind
estrogen
negative syndrome
performance
persistent symptoms
postmenopausal women
raloxifene
randomised controlled trial
reliability
scale
schizophrenia
sex-differences
PERFORMANCE
Estrogen
Schizophrenia
RELIABILITY
SCALE
POSTMENOPAUSAL WOMEN
PERSISTENT SYMPTOMS
NEGATIVE SYNDROME
COGNITION
Antipsychotic medication
Randomised controlled trial
DOUBLE-BLIND
ESTROGEN
Raloxifene
SEX-DIFFERENCES

Access to Document

10.1016/j.conctc.2020.100681Licence: CC BY

Cite this

Brand, B. A., de Boer, J. N., Ophuis, S. B. J. O., Slot, M. I. E., De Wilde, B., Catthoor, K. C. E. E. R., Goverde, A. J., Bakker, P. R., Marcelis, M. C., Grootens, K. P., Luykx, J. J., Heringa, S. M., Weickert, C. S., Sommer, I. E. C., & Weickert, T. W. (2020). Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol. Contemporary Clinical Trials Communications, 20, [100681]. https://doi.org/10.1016/j.conctc.2020.100681

Brand, B.A. ; de Boer, J.N. ; Ophuis, S.B.J.O. ; Slot, M.I.E. ; De Wilde, B. ; Catthoor, K.C.E.E.R. ; Goverde, A.J. ; Bakker, P.R. ; Marcelis, M.C. ; Grootens, K.P. ; Luykx, J.J. ; Heringa, S.M. ; Weickert, C.S. ; Sommer, I.E.C. ; Weickert, T.W. / Raloxifene augmentation in men and women with a schizophrenia spectrum disorder : A study protocol. In: Contemporary Clinical Trials Communications. 2020 ; Vol. 20.

@article{cd6e2dde23e848e3911613fb777f25cc,

title = "Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol",

keywords = "antipsychotic medication, cognition, double-blind, estrogen, negative syndrome, performance, persistent symptoms, postmenopausal women, raloxifene, randomised controlled trial, reliability, scale, schizophrenia, sex-differences, PERFORMANCE, Estrogen, Schizophrenia, RELIABILITY, SCALE, POSTMENOPAUSAL WOMEN, PERSISTENT SYMPTOMS, NEGATIVE SYNDROME, COGNITION, Antipsychotic medication, Randomised controlled trial, DOUBLE-BLIND, ESTROGEN, Raloxifene, SEX-DIFFERENCES",

author = "B.A. Brand and {de Boer}, J.N. and S.B.J.O. Ophuis and M.I.E. Slot and {De Wilde}, B. and K.C.E.E.R. Catthoor and A.J. Goverde and P.R. Bakker and M.C. Marcelis and K.P. Grootens and J.J. Luykx and S.M. Heringa and C.S. Weickert and I.E.C. Sommer and T.W. Weickert",

year = "2020",

month = dec,

day = "1",

doi = "10.1016/j.conctc.2020.100681",

language = "English",

volume = "20",

journal = "Contemporary Clinical Trials Communications",

issn = "2451-8654",

publisher = "Elsevier Inc.",

}

Brand, BA, de Boer, JN, Ophuis, SBJO, Slot, MIE, De Wilde, B, Catthoor, KCEER, Goverde, AJ, Bakker, PR, Marcelis, MC, Grootens, KP, Luykx, JJ, Heringa, SM, Weickert, CS, Sommer, IEC & Weickert, TW 2020, 'Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol', Contemporary Clinical Trials Communications, vol. 20, 100681. https://doi.org/10.1016/j.conctc.2020.100681

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder : A study protocol. / Brand, B.A.; de Boer, J.N.; Ophuis, S.B.J.O.; Slot, M.I.E.; De Wilde, B.; Catthoor, K.C.E.E.R.; Goverde, A.J.; Bakker, P.R.; Marcelis, M.C.; Grootens, K.P.; Luykx, J.J.; Heringa, S.M.; Weickert, C.S.; Sommer, I.E.C.; Weickert, T.W.

In: Contemporary Clinical Trials Communications, Vol. 20, 100681, 01.12.2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Raloxifene augmentation in men and women with a schizophrenia spectrum disorder

T2 - A study protocol

AU - Brand, B.A.

AU - de Boer, J.N.

AU - Ophuis, S.B.J.O.

AU - Slot, M.I.E.

AU - De Wilde, B.

AU - Catthoor, K.C.E.E.R.

AU - Goverde, A.J.

AU - Bakker, P.R.

AU - Marcelis, M.C.

AU - Grootens, K.P.

AU - Luykx, J.J.

AU - Heringa, S.M.

AU - Weickert, C.S.

AU - Sommer, I.E.C.

AU - Weickert, T.W.

PY - 2020/12/1

Y1 - 2020/12/1

KW - antipsychotic medication

KW - cognition

KW - double-blind

KW - estrogen

KW - negative syndrome

KW - performance

KW - persistent symptoms

KW - postmenopausal women

KW - raloxifene

KW - randomised controlled trial

KW - reliability

KW - scale

KW - schizophrenia

KW - sex-differences

KW - PERFORMANCE

KW - Estrogen

KW - Schizophrenia

KW - RELIABILITY

KW - SCALE

KW - POSTMENOPAUSAL WOMEN

KW - PERSISTENT SYMPTOMS

KW - NEGATIVE SYNDROME

KW - COGNITION

KW - Antipsychotic medication

KW - Randomised controlled trial

KW - DOUBLE-BLIND

KW - ESTROGEN

KW - Raloxifene

KW - SEX-DIFFERENCES

U2 - 10.1016/j.conctc.2020.100681

DO - 10.1016/j.conctc.2020.100681

M3 - Article

C2 - 33364517

VL - 20

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

SN - 2451-8654

M1 - 100681

ER -